Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Biosimilars

Business & Regulation Business Practice

Ahead of the Curve

Sitting Down With... Ajaz Hussain, President, National Institute for Pharmaceutical Technology and Education, Minnesota, USA.

Business & Regulation Biosimilars

Land of Opportunity

| Stephanie Sutton

Biosimilars had their big break in the US in 2015, but three years later biosimilars are still struggling to make a mark.

Manufacture Business Practice

Biosimilar Backer

| Stephanie Sutton

Sitting Down With Cyrus Krakaria, President of Biotechnology for Lupin Limited, Biotech Division, India.

Manufacture Biosimilars

Who Wants to Put Biosimilars to the Test

WHO is investigating the potential of certain biosimilars in a prequalification pilot program.

Business & Regulation Biosimilars

A New Supporter

| Stephanie Sutton

Initially, The American College of Rheumatology was cautious about biosimilars, but times have changed.

Discovery & Development Biosimilars

What Regulators Want

| Bruno Speder

The path to market for a biosimilar involves an abbreviated approval process, focused on proving “biosimilarity”.

Discovery & Development Biosimilars

I’m a (Biosimilars) Believer!

| Stephanie Sutton

Why does the full potential of biosimilars remain untapped? Four experts weigh in.

Business & Regulation Biosimilars

Business in Brief

| Stephanie Sutton

The latest business news and views in pharma.

Manufacture Biosimilars

Open Your Mind

| Roisin McGuigan

Why is the pharma industry overly reluctant to accept new ideas?

Manufacture Standards & Regulation

Raising the Biosimilar Banner

| Stephanie Sutton

FDA Commissioner Scott Gottlieb wants more biosimilars on the US market.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register